Sort
11,323 grants matching “glioblastoma”
MOSAIC: Imaging Human Tissue State Dynamics In Vivo
$342,900Kristin R Swanson · Mayo Clinic Arizona · U54 · FY2023 · CA
Research Testbed 2
$342,860David J Odde · University Of Minnesota · U54 · FY2022 · CA
Novel adhesion mechanisms in glioblastoma stem cells
$342,848Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · NS
Role of the Syx-RhoA signaling axis in glioma cell growth and dissemination
$342,835Panagiotis Z Anastasiadis · Mayo Clinic Jacksonville · R01 · FY2019 · NS
Role of the Syx-RhoA signaling axis in glioma cell growth and dissemination
$342,835Panagiotis Z Anastasiadis · Mayo Clinic Jacksonville · R01 · FY2022 · NS
Role of the Syx-RhoA signaling axis in glioma cell growth and dissemination
$342,835Panagiotis Z Anastasiadis · Mayo Clinic Jacksonville · R01 · FY2020 · NS
Mechanisms Promoting Angiogenesis in Glioblastoma
$342,831Candece L Gladson · Cleveland Clinic Lerner Com-Cwru · R01 · FY2013 · CA
Role of the Syx-RhoA signaling axis in glioma cell growth and dissemination
$342,822Panagiotis Z Anastasiadis · Mayo Clinic Jacksonville · R56 · FY2017 · NS
Cytoplasmic Multimerization of the RNA-binding protein HuR is Oncogenic in Glioma
$342,804Louis B Nabors · University Of Alabama At Birmingham · R01 · FY2018 · CA
Dissecting and engineering CAR T-cell function for optimized Immunotherapy
$342,716Weiqiang Chen · New York University · R35 · FY2023 · GM
Dissecting and engineering CAR T-cell function for optimized Immunotherapy
$342,716Weiqiang Chen · New York University · R35 · FY2022 · GM
Dissecting and engineering CAR T-cell function for optimized Immunotherapy
$342,716Weiqiang Chen · New York University · R35 · FY2019 · GM
Dissecting and engineering CAR T-cell function for optimized Immunotherapy
$342,716Weiqiang Chen · New York University · R35 · FY2021 · GM
Dissecting and engineering CAR T-cell function for optimized Immunotherapy
$342,716Weiqiang Chen · New York University · R35 · FY2020 · GM
Targeting Glioblastoma Cells and Tumor Microenvironment with CAR-T Cell Therapy
$342,615Yvonne Yu-Hsuan Chen · University Of California Los Angeles · P50 · FY2023 · CA
Polyamine Catabolism and Therapeutic Resistance in Glioblastoma Multiforme
$342,596Scott Michael Welford · University Of Miami School Of Medicine · R01 · FY2018 · CA
Treatment of glioma with nanocombretastatin with MRI monitoring
$342,554Meser M. Ali · Henry Ford Health System · R01 · FY2017 · CA
Heparan sulfate proteoglycans as critical regulators of brain cancer malignancy
$342,526Joanna Phillips · University Of California, San Francisco · R01 · FY2012 · NS
The role of mTORC2 in reprogramming cancer cell metabolism
$342,474Paul S Mischel · Ludwig Institute For Cancer Res Ltd · R01 · FY2017 · NS
Pathology Core
$342,427Keith L Ligon · Massachusetts General Hospital · P50 · FY2016 · CA
Tumor cell and microenvironment changes causing antiangiogenic therapy resistance
$342,347Manish Aghi · University Of California, San Francisco · R01 · FY2014 · NS
Heparan sulfate proteoglycans as critical regulators of brain cancer malignancy
$342,347Joanna Phillips · University Of California, San Francisco · R01 · FY2014 · NS
Dual Targeting of Brain Tumor Initiating Cells through Inhibition of BMI1 and EZH2 (R01NS103434)
$342,344Jeremy N Rich · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · NS
Transcriptional regulation of gliogenesis in the CNS
$342,344Benjamin Deneen · Baylor College Of Medicine · R01 · FY2016 · NS
Transcriptional regulation of gliogenesis in the CNS
$342,344Benjamin Deneen · Baylor College Of Medicine · R01 · FY2014 · NS